These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23055873)

  • 1. Drug dosing during continuous renal replacement therapies.
    Thompson AJ
    J Pediatr Pharmacol Ther; 2008 Apr; 13(2):99-113. PubMed ID: 23055873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A primer on continuous renal replacement therapy for critically ill patients.
    Joy MS; Matzke GR; Armstrong DK; Marx MA; Zarowitz BJ
    Ann Pharmacother; 1998 Mar; 32(3):362-75. PubMed ID: 9533067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
    Hoff BM; Maker JH; Dager WE; Heintz BH
    Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
    Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M
    Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra Removal by Continuous Renal Replacement Therapy: An Ex Vivo Analysis.
    Dubinsky SDJ; Watt KM; Imburgia CE; Mcknite AM; Hunt JP; Rice C; Rower JE; Edginton AN
    Crit Care Explor; 2023 Dec; 5(12):e1010. PubMed ID: 38107537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should continuous renal replacement therapy be used for 'non-renal' indications in critically ill patients with shock?
    van Bommel EF
    Resuscitation; 1997 Jan; 33(3):257-70. PubMed ID: 9044498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal.
    Berbece AN; Richardson RM
    Kidney Int; 2006 Sep; 70(5):963-8. PubMed ID: 16850023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Dosing Frontier: Retrospective Assessment of Effluent Flow Rates and Residual Renal Function Among Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Lakshmipathy D; Ye X; Kuti JL; Nicolau DP; Asempa TE
    Crit Care Explor; 2024 Apr; 6(4):e1065. PubMed ID: 38533293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit.
    Allegretti AS; Endres P; Parris T; Zhao S; May M; Sylvia-Reardon M; Bezreh N; Culbert-Costley R; Ananian L; Roberts RJ; Lopez N; Charytan DM; Tolkoff-Rubin N
    Am J Nephrol; 2020; 51(4):318-326. PubMed ID: 32097936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New experiences with the therapy of acute kidney injury.
    Kes P; Basić Jukić N
    Prilozi; 2008 Dec; 29(2):119-53. PubMed ID: 19259043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy.
    Jang SM; Yessayan L; Dean M; Costello G; Katwaru R; Mueller BA
    Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management for Electrolytes Disturbances during Continuous Renal Replacement Therapy.
    Baeg SI; Lee K; Jeon J; Jang HR
    Electrolyte Blood Press; 2022 Dec; 20(2):64-75. PubMed ID: 36688209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.
    Cies JJ; Moore WS; Miller K; Small C; Carella D; Conley S; Parker J; Shea P; Chopra A
    Pharmacotherapy; 2015 Feb; 35(2):229-33. PubMed ID: 25556960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetaminophen clearance during ex vivo continuous renal replacement therapies.
    Scoville BA; Vulaj V; Mueller BA; Annich GM; Wagner DS
    J Artif Organs; 2018 Jun; 21(2):215-219. PubMed ID: 29063343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug dosing during continuous renal replacement therapy.
    Churchwell MD; Mueller BA
    Semin Dial; 2009; 22(2):185-8. PubMed ID: 19426426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dialysate flow configurations in continuous renal replacement therapy on solute removal: computational modeling.
    Kim JC; Cruz D; Garzotto F; Kaushik M; Teixeria C; Baldwin M; Baldwin I; Nalesso F; Kim JH; Kang E; Kim HC; Ronco C
    Blood Purif; 2013; 35(1-3):106-11. PubMed ID: 23343554
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.